Back to results
US 2012/0058966 A1Published application
Sphingosine Kinase Inhibitor Prodrugs
AssigneeApogee Biotechnology Corporation
InventorsCharles D. Smith, Yan Zhuang, Lynn W. Maines
Life of this patent
Estimating the term…
Abstract
The invention relates to prodrugs of hydroxyl-substituted adamantane compounds, pharmaceutical compositions thereof, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
Claims26
A compound of the formula (I)
- and pharmaceutically acceptable salts thereof, wherein
- R1 is H, Cl or F;
- R2 is H or alkyl;
- m is 0, 1 or 2;
- n is 1, 2, 3, 4 or 5;
- and
- each R3 is independently H, —C(O)alkyl, —C(O)CH2CH2C(O)OH, R4, —C(O)NR5R6, —P(O)(OR7)2 or glucosyl, provided that at least one R3 is not H,
- wherein
- R4 is a natural or unnatural amino acid linked through the carboxyl moiety as an ester,
- R5 is H or alkyl,
- R6 is H or alkyl, and
- each R7 is independently H or alkyl.
9 more elements
Dependencies are inferred from the claim text.